semaglutide supply news november 2025 Are you eligible? Medicare's new GLP-1 Bridge program will cover certain weight-loss drugs starting this week. But as of now, the program isn't permanent: https://www.wtol.com/article/news/nation-world/medicare-covering-glp-1-weight-loss-drugs-bridge US FDA approves weight loss

Drinking enough water, eating smaller meals, and avoiding heavy foods may help make the adjustment period easier

Examining these complaints provides valuable insight into what new customers might expect and equips them with the knowledge to navigate potential frustrations, ensuring they are well-prepared for their supplement journey

These systems remove guesswork about needle selection and ensure consistent quality

Adherence is another major issue one study suggested that roughly two-thirds of patients discontinue GLP-1 therapy within the first year, often due to high costs, gastrointestinal side effects, lack of perceived benefit, or difficulty maintaining lifestyle changes

SAN DIEGO An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments